Novartis researchers are working to extend the life of organ transplants

How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.

Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Dr. Botond Roska says we should keep our eyes on gene therapy.

Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.

Learn how Novartis researchers are working to outsmart tumors.